School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Department of Health Sciences, College of Natural Science, Dongduk Women's University, Yeji #406, Hwarang-ro 13-gil, Seongbuk-gu, Seoul, 02748, South Korea.
Appl Health Econ Health Policy. 2021 Nov;19(6):941-951. doi: 10.1007/s40258-021-00649-1. Epub 2021 Jun 25.
Major depression in South Korea, which remains under-diagnosed and under-treated, increases the risk of premature death, and reduces quality of life and work productivity. The aim of this study was to quantify the depression-related health and productivity loss in South Korea in terms of life-years lost and productivity-adjusted life-years (PALYs) lost.
Age and sex-specific life table models simulated follow-up of South Koreans with depression aged 15 to 54 years, until 55 years. Depression was defined as major depression. Inputs were drawn from national datasets and published sources. Models were constructed for the cohort with depression and repeated assuming they had no depression. Differences in total deaths, years of life, and PALYs represented the impact of depression. PALYs were ascribed a financial value equivalent to total gross domestic product (GDP) divided by the number of equivalent full-time workers (KRW81,507,146 or USD74,748). All outcomes were discounted by 3% per annum.
In 2019, there were more than 500,000 people aged 15-54 years with major depression in South Korea. We predicted that until this cohort reached age 55 years, and assuming 22.2% of people with depression are treated, depression led to 12,000 excess deaths, more than 55,000 discounted years of life lost and 1.6 million discounted PALYs lost, equating to KRW133 trillion (USD122 billion) in lost GDP. Applying treatment-related response and remission rates of 11.8% and 42.1%, respectively, and a non-response/non-remission rate of 46.1%, increased the total number of PALYs lost by almost 6.0%.
Our study highlights the considerable productivity loss attributable to depression among South Koreans over their working lifetime. Better prevention and treatment of depression is needed for long-term economic gains.
韩国的重度抑郁症未得到充分诊断和治疗,这增加了早逝的风险,并降低了生活质量和工作生产力。本研究旨在根据生命年损失和生产力调整生命年(PALYs)损失来量化韩国因抑郁导致的健康和生产力损失。
年龄和性别特定的生命表模型模拟了 15 至 54 岁患有抑郁症的韩国人的后续情况,直到 55 岁。抑郁症的定义为重度抑郁症。输入数据来自国家数据集和已发表的来源。为患有抑郁症的队列构建了模型,并重复了假设他们没有抑郁症的情况。总死亡人数、生命年和 PALYs 的差异代表了抑郁症的影响。PALYs 的赋值为总国内生产总值(GDP)除以等效全职工人人数(韩元 81507146 或美元 74748)的财务价值。所有结果均按每年 3%贴现。
2019 年,韩国有超过 50 万 15-54 岁的重度抑郁症患者。我们预测,直到该队列达到 55 岁,并且假设 22.2%的抑郁症患者接受治疗,抑郁症将导致 12000 人死亡,超过 55000 个贴现生命年损失和 160 万贴现 PALYs 损失,相当于韩元 1330 万亿(美元 1220 亿)的 GDP 损失。应用相关治疗的反应和缓解率分别为 11.8%和 42.1%,以及非反应/非缓解率为 46.1%,将损失的总 PALYs 数增加了近 6.0%。
我们的研究强调了韩国人在整个工作生涯中因抑郁导致的巨大生产力损失。需要更好地预防和治疗抑郁症,以实现长期的经济收益。